Ameritas Investment Partners’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,427
| Closed | -$153K | – | 3138 |
|
|
2025
Q3 | $153K | Sell |
10,427
-2,316
| -18% | -$23.6K | ﹤0.01% | 1402 |
|
|
2025
Q2 | $125K | Buy |
12,743
+1,422
| +13% | +$11.8K | ﹤0.01% | 1600 |
|
|
2025
Q1 | $82.3K | Buy |
11,321
+3,435
| +44% | +$30K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $61.7K | Hold |
7,886
| – | – | ﹤0.01% | 2060 |
|
|
2024
Q3 | $58.4K | Hold |
7,886
| – | – | ﹤0.01% | 2096 |
|
|
2024
Q2 | $63.2K | Hold |
7,886
| – | – | ﹤0.01% | 2006 |
|
|
2024
Q1 | $91.8K | Buy |
7,886
+1,744
| +28% | +$19.3K | ﹤0.01% | 1794 |
|
|
2023
Q4 | $68.6K | Hold |
6,142
| – | – | ﹤0.01% | 1973 |
|
|
2023
Q3 | $94.8K | Buy |
6,142
+1,037
| +20% | +$17.4K | ﹤0.01% | 1695 |
|
|
2023
Q2 | $96.7K | Buy |
+5,105
| New | +$89.6K | ﹤0.01% | 1621 |
|
|
2022
Q2 | – | Sell |
-560
| Closed | -$2K | – | 3119 |
|
|
2022
Q1 | $2K | Hold |
560
| – | – | ﹤0.01% | 3045 |
|
|
2021
Q4 | $7K | Hold |
560
| – | – | ﹤0.01% | 2983 |
|
|
2021
Q3 | $11K | Hold |
560
| – | – | ﹤0.01% | 2909 |
|
|
2021
Q2 | $10K | Hold |
560
| – | – | ﹤0.01% | 2927 |
|
|
2021
Q1 | $13K | Hold |
560
| – | – | ﹤0.01% | 2738 |
|
|
2020
Q4 | $14K | Hold |
560
| – | – | ﹤0.01% | 2643 |
|
|
2020
Q3 | $14K | Buy |
560
+305
| +120% | +$9.67K | ﹤0.01% | 2554 |
|
|
2020
Q2 | $5K | Hold |
255
| – | – | ﹤0.01% | 2950 |
|
|
2020
Q1 | $6K | Hold |
255
| – | – | ﹤0.01% | 2744 |
|
|
2019
Q4 | $7K | Buy |
+255
| New | +$7.1K | ﹤0.01% | 2829 |
|
Other funds holding ETNB
Ameritas Investment Partners's ETNB Position: Q4 2025 in Review
Ameritas Investment Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 10,427 shares — an estimated $153K sold.
Ameritas Investment Partners first reported a position in ETNB in Q4 2019 and held it in 20 quarters. The position peaked at $153K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Ameritas Investment Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 10,427 89bio shares in Q4 2025, an estimated $153K.
- Ameritas Investment Partners first reported a position in 89bio in Q4 2019 and held it in 20 quarters.
- Ameritas Investment Partners's 89bio position peaked at $153K in Q3 2025.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Ameritas Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.